Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Pestell Group has acquired Pro-Ag Products and Verus Animal Nutrition through its Pestell Minerals & Ingredients (PMI) unit for an undisclosed fee.
Ongoing media rumors have suggested Elanco's plan to purchase Bayer Animal Health could be executed next week.
Phibro Animal Health has acquired microbial products specialist Osprey Biotechnics for an undisclosed fee.
Elanco has significantly bolstered its swine vaccine portfolio by acquiring Canadian company Prevtec Microbia.
Zoetis is to purchase Platinum Performance – a Californian family-owned firm focused on nutrition for dogs, cats and horses.
Piedmont Animal Health has sold its Flynexx fly control brand to an affiliate of Japan's Sumitomo Chemical.
A strong majority of shareholders in Aratana Therapeutics have voted to accept the proposed bid for the company by Elanco.
Sweden's CombiGene has moved a step closer to purchasing pet gene therapy specialist Panion Animal Health.
More pharma companies are exiting the animal health space. With animal health becoming an increasingly independent sector, Animal Pharm editor Joseph Harvey looks at the remaining pharma businesses that still hold an interest in veterinary medicine.
The latest rumor regarding the future of Bayer Animal Health has suggested Elanco could be poised to make a bid.
Dechra Pharmaceuticals has acquired an extra 15% stake in Australian firm Medical Ethics for Aus$13.5 million ($9.5 million).
Ceva Santé Animale's finalized acquisition of IDT Biologika's animal health assets has helped the firm move closer to having an evenly balanced product portfolio.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.